Theravance Biopharma, Inc. (TBPH)
16.41
+0.31
(+1.93%)
USD |
NASDAQ |
Apr 07, 15:34
Theravance Biopharma SG&A Expense (TTM) : 78.40M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Integer Holdings Corp. | 211.75M |
| QuidelOrtho Corp. | 746.30M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Viatris, Inc. | 3.794B |
| Nektar Therapeutics | 68.67M |